Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95. https://doi.org/10.1016/s1470-2045(10)70218-7.
Google ScholarÂ
Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol. 2013;10:90–99. https://doi.org/10.1038/nrclinonc.2012.209.
Google ScholarÂ
Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Prim. 2018;4:17105. https://doi.org/10.1038/nrdp.2017.105.
Google ScholarÂ
Pressoir M, Desné S, Berchery D, Rossignol G, Poiree B, Meslier M, et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010;102:966–71. https://doi.org/10.1038/sj.bjc.6605578.
Google ScholarÂ
Argilés J, Busquets S, Stemmler B, López-Soriano F. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14:754–62. https://doi.org/10.1038/nrc3829.
Google ScholarÂ
Dev R, Hui D, Chisholm G, Delgado-Guay M, Dalal S, Del Fabbro E, et al. Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic. J Cachexia Sarcopenia Muscle. 2015;6:95–98. https://doi.org/10.1002/jcsm.12014.
Google ScholarÂ
Vazeille C, Jouinot A, Durand J-P, Neveux N, Boudou-Rouquette P, Huillard O, et al. Relation between hypermetabolism, cachexia, and survival in cancer patients: a prospective study in 390 cancer patients before initiation of anticancer therapy. Am J Clin Nutr. 2017;105:1139–47. https://doi.org/10.3945/ajcn.116.140434.
Google ScholarÂ
von Haehling S, Anker M, Anker S. Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016. J Cachexia Sarcopenia Muscle. 2016;7:507–9. https://doi.org/10.1002/jcsm.12167.
Google ScholarÂ
Mendes MC, Pimentel GD, Costa FO, Carvalheira JB. Molecular and neuroendocrine mechanisms of cancer cachexia. J Endocrinol. 2015;226:R29–43. https://doi.org/10.1530/joe-15-0170.
Google ScholarÂ
Li L, Ling ZQ. Mechanisms of cancer cachexia and targeted therapeutic strategies. Biochim Biophys Acta Rev Cancer. 2024;1879:189208. https://doi.org/10.1016/j.bbcan.2024.189208.
Google ScholarÂ
Bianchini C, Bonomo P, Bossi P, Caccialanza R, Fabi A. Bridging gaps in cancer cachexia Care: current insights and future perspectives. Cancer Treat Rev. 2024;125:102717. https://doi.org/10.1016/j.ctrv.2024.102717.
Google ScholarÂ
Meza-Valderrama D, Marco E, Dávalos-Yerovi V, Muns MD, Tejero-Sánchez M, Duarte E, et al. Sarcopenia, malnutrition, and cachexia: adapting definitions and terminology of nutritional disorders in older people with cancer. Nutrients. 2021;13:761. https://doi.org/10.3390/nu13030761.
Google ScholarÂ
Martin L, Senesse P, Gioulbasanis I, Antoun S, Bozzetti F, Deans C, et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015;33:90–99. https://doi.org/10.1200/jco.2014.56.1894.
Google ScholarÂ
Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–54. https://doi.org/10.1007/s00259-014-2961-x.
Google ScholarÂ
Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480–508. https://doi.org/10.2967/jnumed.107.047787.
Google ScholarÂ
Nakamoto R, Okuyama C, Ishizu K, Higashi T, Takahashi M, Kusano K, et al. Diffusely Decreased Liver Uptake on FDG PET and Cancer-Associated Cachexia With Reduced Survival. Clin Nucl Med. 2019;44:634–42. https://doi.org/10.1097/rlu.0000000000002658.
Google ScholarÂ
da Cunha Júnior AD, Silveira MN, Takahashi MES, de Souza EM, Mosci C, Ramos CD, et al. Visceral adipose tissue glucose uptake is linked to prognosis in multiple myeloma patients: an exploratory study. Clin Nutr. 2021;40:4075–84. https://doi.org/10.1016/j.clnu.2021.02.010.
Google ScholarÂ
Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278:563–77. https://doi.org/10.1148/radiol.2015151169.
Google ScholarÂ
Yip SS, Aerts HJ. Applications and limitations of radiomics. Phys Med Biol. 2016;61:R150–166. https://doi.org/10.1088/0031-9155/61/13/r150.
Google ScholarÂ
Ferrer M, Anthony TG, Ayres JS, Biffi G, Brown JC, Caan BJ, et al. Cachexia: A systemic consequence of progressive, unresolved disease. Cell. 2023;186:1824–45. https://doi.org/10.1016/j.cell.2023.03.028.
Google ScholarÂ
Mu W, Katsoulakis E, Whelan CJ, Gage KL, Schabath MB, Gillies RJ. Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors. Br J Cancer. 2021;125:229–39. https://doi.org/10.1038/s41416-021-01375-0.
Google ScholarÂ
Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749–62. https://doi.org/10.1038/nrclinonc.2017.141.
Google ScholarÂ
Zwanenburg A, Vallières M, Abdalah MA, Aerts H, Andrearczyk V, Apte A, et al. The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology. 2020;295:328–38. https://doi.org/10.1148/radiol.2020191145.
Google ScholarÂ
Song Y, Zhang J, Zhang YD, Hou Y, Yan X, Wang Y, et al. FeAture Explorer (FAE): A tool for developing and comparing radiomics models. PLoS One. 2020;15:e0237587 https://doi.org/10.1371/journal.pone.0237587.
Google ScholarÂ
Prado CM, Sawyer MB, Ghosh S, Lieffers JR, Esfandiari N, Antoun S, et al. Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential? Am J Clin Nutr. 2013;98:1012–9. https://doi.org/10.3945/ajcn.113.060228.
Google ScholarÂ
Lieffers JR, Mourtzakis M, Hall KD, McCargar LJ, Prado CMM, Baracos VE. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr. 2009;89:1173–9. https://doi.org/10.3945/ajcn.2008.27273.
Google ScholarÂ
Ferrara D, Abenavoli EM, Beyer T, Gruenert S, Hacker M, Hesse S, et al. Detection of cancer-associated cachexia in lung cancer patients using whole-body [18F]FDG-PET/CT imaging: a multi-centre study. J Cachexia Sarcopenia Muscle. 2024;15:2375–86. https://doi.org/10.1002/jcsm.13571.
Google ScholarÂ
Jiang Y, Huang M, Zhao Y, Dai J, Yang Q, Tang X, et al. A [18F]FDG PET based nomogram to predict cancer-associated cachexia and survival outcome: a multi-center study. Nutrition. 2025;129:112593. https://doi.org/10.1016/j.nut.2024.112593.
Google ScholarÂ
Jiang Y, Wu H, Zhao Y, Cui Y, Dai J, Huang S, et al. Abnormal [18F]FDG uptake in liver and adipose tissue: a potential imaging biomarker for cancer-associated cachexia. Eur Radio. 2023;33:2561–73. https://doi.org/10.1007/s00330-022-09226-z.
Google ScholarÂ
Richey LM, George JR, Couch ME, Kanapkey BK, Yin X, Cannon T, et al. Defining cancer cachexia in head and neck squamous cell carcinoma. Clin Cancer Res. 2007;13:6561–7. https://doi.org/10.1158/1078-0432.Ccr-07-0116.
Google ScholarÂ
Awadallah SM, Elhag HAO, Eltohami Y. Cachexia in oral squamous cell carcinoma Sudanese patients: an exploratory study. BMC Oral Health. 2025;25:428. https://doi.org/10.1186/s12903-025-05793-x.
Google ScholarÂ
Zhang C, Fu Y, Sun Y, Li R, Zhou J, Wang J, et al. Development and validation of a prognostic model for cachexia in postoperative gastric cancer patients with low nutritional risk: a dual-center retrospective cohort study. Surg Endosc. 2025;39:237–48. https://doi.org/10.1007/s00464-024-11367-9.
Google ScholarÂ
Birgegård G, Aapro MS, Bokemeyer C, Dicato M, Drings P, Hornedo J, et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology. 2005;68:3–11. https://doi.org/10.1159/000083128.
Google ScholarÂ
Zhang XW, Zhang Q, Song MM, Zhang KP, Zhang X, Ruan GT, et al. The prognostic effect of hemoglobin on patients with cancer cachexia: a multicenter retrospective cohort study. Support Care Cancer. 2022;30:875–85. https://doi.org/10.1007/s00520-021-06486-1.
Google ScholarÂ
Koh K, Scott R, Cespedes Feliciano EM, Janowitz T, Goncalves MD, White EP, et al. Cancer-associated cachexia: bridging clinical findings with mechanistic insights in human studies. Cancer Discov. 2025: Of1-of26. https://doi.org/10.1158/2159-8290.Cd-25-0293
Berriel Diaz M, Rohm M, Herzig S. Cancer cachexia: multilevel metabolic dysfunction. Nat Metab. 2024;6:2222–45. https://doi.org/10.1038/s42255-024-01167-9.
Google ScholarÂ
Shiyam Sundar LK, Yu J, Muzik O, Kulterer OC, Fueger B, Kifjak D, et al. Fully automated, semantic segmentation of whole-body 18F-FDG PET/CT images based on data-centric artificial intelligence. J Nucl Med. 2022;63:1941–8. https://doi.org/10.2967/jnumed.122.264063.
Google ScholarÂ
Mai DVC, Drami I, Pring ET, Gould LE, Lung P, Popuri K, et al. A systematic review of automated segmentation of 3D computed-tomography scans for volumetric body composition analysis. J Cachexia Sarcopenia Muscle. 2023;14:1973–86. https://doi.org/10.1002/jcsm.13310.
Google ScholarÂ

![Pre-therapeutic prediction of cachexia in lymphoma patients using [18F]FDG PET radiomics of muscle and fat Pre-therapeutic prediction of cachexia in lymphoma patients using [18F]FDG PET radiomics of muscle and fat](https://news.shareyourcancerstories.com/wp-content/uploads/2026/08/Pre-therapeutic-prediction-of-cachexia-in-lymphoma-patients-using-18FFDG-PET.png)